Kristen Dahlgren: Revolutionizing Oncology by Preventing Recurrence With Therapeutic Vaccines
Kristen Dahlgren/LinkedIn Elen Baloyan/LinkedIn

Kristen Dahlgren: Revolutionizing Oncology by Preventing Recurrence With Therapeutic Vaccines

Kristen Dahlgren, Chief External Affairs Officer at Parker Institute for Cancer Immunotherapy, shared Elen Baloyan’s, Oncology Fellow at Yeolyan Hematology and Oncology Center, Managing Editor of OncoDaily, post on adding:

“Thank you Elen Baloyan, MD and OncoDaily! I am so excited to be joining the incredible work of Karen Knudsen MBA PhD and Parker Institute for Cancer Immunotherapy.

This is the non-profit model I always wanted to build- something that gets cutting edge therapies out of the labs and into patients as quickly as possible with high level collaboration on development and commercialization. It can’t happen without that bold end to end system.

I truly believe this is the moment and the organization that will change cancer care for all of us!”

Quoting Elen Baloyan’s post:

“Thank you Karen Knudsen MBA PhD and Kristen Dahlgren for the conversation on cancer vaccines and Parker Institute for Cancer Immunotherapy’s next chapter.”

Other articles featuring Kristen Dahlgren and Elen Baloyan on OncoDaily.